¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"essential progressive deafness"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • essential pentosuria
    º»ÅÂÆæÅä¿À½º´¢
  • essential telangiectasia
    º»Å¸ð¼¼Ç÷°üÈ®Àå(Áõ)
  • essential thrombocytopenia
    º»ÅÂÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • essential tremor
    º»Å¶³¸²
  • essential vertigo
    º»ÅÂÇö±âÁõ
  • minimum essential medium
    ÃÖ¼ÒÇʼö¿µ¾ç¹èÁö
  • apoplectic deafness
    Áßdz³­Ã»
  • acquired deafness
    ÈÄõ³­Ã»
  • bass deafness
    ÀúÀ½³­Ã»
  • boilermaker¡¯s deafness
    º¸ÀÏ·¯Á¦Á¶°ø³­Ã»
  • conduction deafness
    Àüµµ³­Ã»
  • congenital word deafness
    ¼±Ãµ¸»±Í¸ÔÀ½, ¼±Ãµ¾î³ó
  • cortical deafness
    °ÑÁú³­Ã», ÇÇÁú³­Ã»
  • central deafness
    ÁßÃß³­Ã»
  • ceruminal deafness
    ±ÍÁöÅ¿³­Ã»
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • essential pentosuria
    º»ÅÂÆæÅä¿À½º´¢Áõ
  • essential telangiectasia
    º»Å¸ð¼¼Ç÷°üÈ®ÀåÁõ,
  • essential tremor
    º»Å¶³¸², À¯Àü¶³¸², ¿øÀθ𸦶³¸²
  • essential vertigo
    ¿øÀκҸí¾îÁö·³, º»ÅÂÇö±âÁõ
  • essential melanotic mucosal hyperplasia
    º»ÅÂÁ¡¸·¸á¶ó´ÑÁ¡¸·Áõ½Ä
  • minimum essential medium
    ÃÖ¼ÒÇʼö¿µ¾ç¹èÁö
  • acquired progressive lymphangioma
    ÈÄõÁøÇาÇÁ°üÁ¾
  • idiopathic progressive atrophoderma
    ¿øÀκҸíÁøÇàÇǺÎÀ§ÃàÁõ
  • neural progressive muscular atrophy
    ½Å°æÁøÇà±ÙÀ°À§Ãà
  • progressive spinal amyotrophy
    ÁøÇàô¼ö±ÙÀ°À§ÃàÁõ
  • chronic progressive disciform granulomatosis
    ¸¸¼ºÁøÇà¿ø¹ÝÀ°¾ÆÁ¾Áõ
  • progressive case
    ÁøÇ༺¿¹
  • progressive diaphyseal dysplasia
    ÁøÇà»À¸öÅëÇü¼ºÀÌ»ó, ÁøÇà°ñ°£Çü¼ºÀÌ»ó
  • progressive muscular dystrophy
    ÁøÇà±ÙÀ°ÅðÇàÀ§Ãà
  • progressive pigmentary dermatosis
    ÁøÇà»ö¼ÒÇǺκ´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pocket handkerchief deafness
    ¿ª±â·ù¼º ³­Ã», ÄÚ¸¦ ¼¼°Ô Ç®À½
  • psychic deafness
    Á¤½Å·Õ(ïñãêÖì).
  • psychic deafness
    Á¤½Å³ó(ïñãêÖì).
  • acquired progressive lymphangioma
    ÈÄõ¼º ÁøÇ༺ ¸²ÇÁ°üÁ¾
  • hereditary progressive mucinous histiocytosis X
    À¯Àü¼º ÁøÇ༺ Á¡¾×¼ºÁ¶Á÷±¸Áõ
  • infantile progressive spinal muscular atrophy
    ¿µ¾ÆÁøÇ༺ ô¼ö¼º ±ÙÀ§Ãà(Áõ).
  • progressive
    ÁøÇ༺
  • progressive
    ÁøÇ༺ÀÇ(òäú¼àõ¡­), Á÷Áø(¼º)ÀÇ(òÁòä(àõ)¡­)
  • progressive bulbar palsy
    ÁøÇ༺ ±¸<¿¬¼ö>¸¶ºñ(òäú¼àõϹ<æÅâÐ> Ýö).
  • progressive cardiomyopathic lentiginosis
    ÁøÇ༺ ½É±Ùº´¼º ÈæÀÚÁõ
  • progressive case
    ÁøÇ༺ ¿¹.
  • progressive diaphyseal dysplasia
    ÁøÇ༺ °ñ°£¼º ÀÌÇü¼º(Áõ)(òäú¼àõÍéÊÏàõì¶ û¡à÷ñø).
  • progressive diaphyseal dysplasia
    ÁøÇ༺ °ñ°£¼º ÀÌÇü¼º(Áõ)(òäú¼àõ ÍéÊÏàõ ì¶û¡à÷(ñø))
  • progressive diffuse keratoderma
    ÁøÇ༺ ±¤¹üÀ§ °¢ÇÇÁõ
  • progressive external ophthalmoplegia
    ÁøÇ༺¿Ü¾È±Ù¸¶ºñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • essential elements
    Çʼö¿ø¼Ò(ù±âÎêªáÈ).
  • essential fatty acid
    Çʼö(ù±âÎ)Áö¹æ»ê(ò·Û¸ß«)
  • essential fatty acids
    ÇʼöÁö¹æ»ê.
  • essential fever
    º»Å¿­(Üâ÷¾æð).
  • essential fructosuria
    º»Å¼º(Áø¼º) °ú´ç´¢
  • essential growth factor
    ÇʼöÁõ½ÄÀÎÀÚ
  • essential hematuria
    º»Å¼º Ç÷´¢.
  • essential hemorrhage
    º»Å¼º ÃâÇ÷.
  • essential hyperkinesia
    º»Å¼º °ú¿îµ¿Áõ.
  • essential hypernatremia
    º»Å¼º °í³ªÆ®·ý Ç÷Áõ, º»Å¼º °í
  • essential hypertension
    º»Å¼º °íÇ÷¾Ð.
  • essential hypertension
    º»Å¼º(Üâ÷¾àõ)°íÇ÷¾Ð(ÍÔúìäâ)
  • essential hyponatremia
    º»Å¼º Àú³ªÆ®·ýÇ÷Áõ.
  • essential hypotension
    º»Å¼º ÀúÇ÷¾ÐÁõ.
  • essential iris atrophy
    º»Å¼ºÈ«Ã¤À§Ãà, Ư¹ß¼ºÈ«Ã¤À§Ãà
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PML peripheral motor latency; polymorphonuclear leukocyte; posterior mitral leaflet; progressive multifo...
PR by way of the rectum [Lat. per rectum]; far point [of accommodation] [Lat. punctum remotum]; palindr...
PSS painful shoulder syndrome; physiologic saline solution; porcine stress syndrome; primary Sjogren syn...
SPS scapuloperoneal syndrome; shoulder pain and stiffness; simple partial seizures; slow-progressive sch...
CHARGE Associations   Coloboma
  Heart disease
  Atresia choanae
  Reta...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EH Essential Hypertension
EMC Essential Mixed Cryoglobulinemia
ET Essential Thrombocythemia
ET Essential Tremor
EAA Essential amino acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nerve deafness
    ½Å°æ ³ó
  • perceptive deafness
    °¨À½ ³­Ã»
  • perinatal deafness
    ÁÖ»ê±â ³ó
  • senile deafness
    ³ëÀμº ³­Ã»ÀÇ
  • surdity : µ¿ÀǾî=deafness.

    surface

    ¸é, Ç¥¸é
  • tone deafness
    À½Ä¡, ½ÇÀ½¾ÇÁõ
    µ¿ÀǾî=amusia.
  • chronic progressive disciform granulomatosis
    ¸¸¼º ÁøÇ༺ ¿øÆÇ»ó À°¾ÆÁ¾Áõ
  • familial progressive sensorineural hearing loss
    °¡Á·¼º ÁøÇ༺ °¨°¢ ½Å°æ¼º ³­Ã»
  • juvenile progressive muscular atrophy
    ¿¬¼Ò¼º ÁøÇ༺ ±Ù À§ÃàÁõ
  • progressive
    ÁøÇ༺ÀÇ, Á÷ÁøÀÇ, Á÷Áø¼ºÀÇ
  • progressive bone cyst
    Á¡Áø¼º °ñ ³¶Á¾
  • progressive bulbar palsy
    ÁøÇ༺ ¿¬¼ö ¸¶ºñ
  • progressive cystic swelling
    ÁøÇ༺ ³¶Á¾¼º Á¾Ã¢
  • progressive diaphyseal
    ÁøÇ༺ °ñ°£
  • progressive dystrophic ophthalmoplegia
    ÁøÇ༺ ÀÌ¿µ¾ç¼º ¾È±Ù ¸¶ºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
Scheibe's deafness Deafness (may be unilateral) due to cochleosaccular dysplasia; usually autosomal recessive inheritance.
(05 Mar 2000)
high frequency deafness Selective loss of hearing acuity for high frequencies, usually associated with neurosensory damage; common in acoustic trauma.
(05 Mar 2000)
psychogenic deafness Hearing loss without evidence of organic cause or malingering; often follows severe psychic shock.
Synonym: functional deafness, hysterical deafness.
(05 Mar 2000)
sensorineural deafness Hearing impairment due to disorders of the cochlear division of the 9th cranial nerve (auditory nerve), the cochlea, or the retrocochlear nerve tracts, as opposed to conductive deafness.
(05 Mar 2000)
hysterical deafness Hearing loss without evidence of organic cause or malingering; often follows severe psychic shock.
Synonym: functional deafness, hysterical deafness.
(05 Mar 2000)
nerve deafness Neural deafness, former terms for sensorineural deafness.
(05 Mar 2000)
noise-induced deafness A type of sensorineural deafness caused by prolonged exposure to loud sounds, e.g., jet engines.
(05 Mar 2000)
deafness A condition in which the sense of hearing in both ears is not functional for ordinary purposes of life. The hearing level for speech is approximately 71 decibels I.s.o. (international organization for standardization) or 61 db a.s.a. (american standards association) or greater.
(12 Dec 1998)
deafness, sudden Sensorineural hearing loss which develops over a period of hours or a few days, varying in severity from mild to total.
(12 Dec 1998)
drugs, essential Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3)
(12 Dec 1998)
industrial deafness Synonym: acoustic trauma deafness.
(05 Mar 2000)
occupational deafness Sensorineural hearing loss due to overexposure to high intensity noise levels.
Synonym: boilermaker's deafness, industrial deafness, occupational deafness.
(05 Mar 2000)
organic deafness Deafness due to a pathologic process or an organic aetiology, as opposed to psychogenic deafness.
(05 Mar 2000)
osteolysis, essential Syndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive (gorham disease), multicentric (hajdu-cheney syndrome, winchester syndrome), or carpal/tarsal.
(12 Dec 1998)
Eagle's minimum essential medium A tissue culture medium similar to Eagle's basal medium but with different amounts and a few exclusions (e.g., antibiotics and phenol red).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • progressive proof
    (»öÀÇ) ´Ü°èº° ±³Á¤¼â
  • progressive rock
    ÇÁ·Î±×·¹½Ãºê ·Ï
  • progressive soul
    ÇÁ·Î±×·¹½Ãºê ¼Ò¿ï
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á